Hunan Fangsheng Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Fangsheng Pharmaceutical Co Ltd with three other
companies in this sector in China:
Shandong Wohua Pharmaceutical Co., Ltd.
sales of 562.80 million Chinese Renmimbi [US$87.47 million]
of which 100%
was Medical Industry),
Furen Pharmaceutical Group Industry Co Ltd
(495.63 million Chinese Renmimbi [US$77.03 million]
of which 95%
was Pharmaceutical Industry), and
Beijing Beilu Pharmaceutical Company Limited
(498.81 million Chinese Renmimbi [US$77.52 million]
of which 94%
was Pharmaceutical Sales).
Hunan Fangsheng Pharmaceutical Co Ltd reported sales of 534.20 million Chinese Renmimbi (US$83.03 million)
December of 2016.
increase of 14.0%
versus 2015, when the company's sales were 468.47 million Chinese Renmimbi.
Sales at Hunan Fangsheng Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 103%).